Le produit a bien été ajouté au panier.

discount label
Mal-LYLVCGERG-OH
Vue en 3D

Biosynth logo

Mal-LYLVCGERG-OH

Ref. 3D-PP48834

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mercredi 6 novembre 2024

Informations sur le produit

Nom :
Mal-LYLVCGERG-OH
Description :

Peptide Mal-LYLVCGERG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Mal-LYLVCGERG-OH include the following: During the early prediabetic period in NOD mice, the pathogenic CD8+ T-cell population comprises multiple antigenic specificities TP DiLorenzo, SM Lieberman , T Takaki, S Honda - Clinical , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661602952988 Peripheral proinsulin expression controls low-avidity proinsulin-reactive CD8 T cells in type 1 diabetes TC Thayer, JA Pearson, E De Leenheer , SJ Hanna - Diabetes, 2016 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/65/11/3429/17484 Convective-heating thermal decomposition/digestion of peptides and proteins on surfaces R Zhou, F Basile - Journal of Analytical and Applied Pyrolysis, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165237016307987 Convective-Heating Thermal Decomposition/Digestion R Zhou, F Basile - Digestion, 2014 - academia.eduhttps://www.academia.edu/download/111737285/j.jaap.2017.07.00420240223-1-9015as.pdf A Single L/D-Substitution at Q4 of the mInsA2-10 Epitope Prevents Type 1 Diabetes in Humanized NOD Mice M Zhang, Y Wang, X Li, G Meng, X Chen - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.713276/full Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies M Clement , JA Pearson, S Gras , HA Van Den Berg - Scientific reports, 2016 - nature.comhttps://www.nature.com/articles/srep35332 Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands LG Petrich de Marquesini - European journal of , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200737762 Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas L Wang, X Li, S Yang, X Chen, J Li, S Wang - Journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391922002706 Peptide-specific cytotoxicity of T lymphocytes against glutamic acid decarboxylase and insulin in type 1 diabetes mellitus K Kimura, T Kawamura, S Kadotani, H Inada - Diabetes research and , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168822700002254 The development of a sub/supercritical fluid chromatography based purification method for peptides K Govender , T Naicker , S Baijnath , HG Kruger - of Pharmaceutical and , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708520314254 Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells JA Pearson, TC Thayer, JE McLaren, K Ladell - Diabetes, 2016 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/65/6/1679/35164 Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2Kd that stimulates CD8 T cells in insulin-dependent diabetes FS Wong , AK Moustakas , L Wen - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.072037299 Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes F Arikat, SJ Hanna, RK Singh, L Vilela, FS Wong - Journal of controlled , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365920301218 Adoptive transfer of autoimmune diabetes using immunodeficient nonobese diabetic (NOD) mice E De Leenheer , FS Wong - Type-1 Diabetes: Methods and Protocols, 2016 - Springerhttps://link.springer.com/protocol/10.1007/7651_2015_294 MCS-18, a novel natural plant product prevents autoimmune diabetes C Seifarth, L Littmann, Y Resheq, S Rössner - Immunology , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247811001325 Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells C Haase, L Yu, G Eisenbarth - Clinical & Experimental , 2010 - academic.oup.comhttps://academic.oup.com/cei/article-abstract/160/3/331/6428884 Presentation of Antigen by Endothelial Cells and Chemoattraction Are Required for Homing of Insulin-specific CD8+ T Cells AY Savinov , FS Wong , AC Stonebraker - The Journal of , 2003 - rupress.orghttps://rupress.org/jem/article-abstract/197/5/643/39754 Contribution of Fas to diabetes development AY Savinov , A Tcherepanov - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0237359100 Progression of autoimmune diabetes driven by avidity maturation of a T-cell population A Amrani, J Verdaguer , P Serra, S Tafuro, R Tan - Nature, 2000 - nature.comhttps://www.nature.com/articles/35021081

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP48834 Mal-LYLVCGERG-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".